I know it's been discussed that Covidien buy out Nuvo after approval
but I think with the shares trading where they are it's more likley.
Just using some simple #'s Shares are 410M (assuming the warrants go
through)  and in the debt of roughly 20M and cash 29M + 9M for
warrants totaling 38M + 2M is assests brings up to around 40M + or -.
So if Covidien put in an offer for 50 cents a share 205M + 20M (debt)
- 40M (cash + assets) = 185M to own Nuvo. If I was Covidien I would be
all over this, I didnt count in the 15M they just got for approval and
if reach the goals 100M, they invested 115M they could own Nuvo for
70M more and would give them Pennsaid Plus and the WF10 drugs which
would be really cheap! Most people would want the share price to be
higher and so would I, at 75 cents a share it would cost them
additional 172M which is still reasonable.

These were just rough #'s but I think it's pretty sound and with out
knowing the actual agreement it's anybodys guess. I find it a little
suspect that the terms of the agreement still havent been released and
they only thing I think think of is there is a buyout clause somewhere
in it.

Anybody else thinking the same as me on this or am I out to lunch?

On Nov 6, 10:33 am, Rudee <rude...@gmail.com> wrote: